To detect and identify adenovirus (Ad), we used a combination of PCR and restriction fragment length polymorphism (RFLP) analysis. Nested PCR with two primer sets that hybridize to the conserved region for hexon proteins of 14 prototypes of Ad, Ad serotype 1 (Ad1) to Ad8, -11, -14, -19, -37, -40, and -41, amplified a 956-bp DNA fragment. The amplified fragments from the 14 prototypes were completely differentiated with a combination of three restriction endonucleases, EcoT14I, HaeIII, and HinfI. We applied this new method for 127 samples of conjunctival scrapings from patients with conjunctivitis and compared the results with those obtained with the combination of culture isolation and a neutralization test (NT). PCR gave a positive result in 69 of 127 cases (54.3%), while only 61 of the 127 samples (48.0%) tested positive by culture isolation. Compared with isolation, the PCR method had a sensitivity of 100% (61 of 61). Positive PCR samples were further classified as Ad37 (59.5%), -3 (31.9%), -11 (4.3%), -8 (2.9%), and -4 (1.4%) by PCR-RFLP analysis. Of eight samples that were PCR positive and culture isolation negative, six were Ad37 and two were Ad8 by PCR-RFLP analysis. These differentiations of isolation-positive samples were identical to the results obtained by the NT. It took only 3 days to detect and identify Ad by PCR-RFLP analysis, whereas it took at least 3 weeks by culture isolation and NT. Our newly developed method of detecting and typing human Ad by PCR-RFLP analysis is more sensitive, accurate, and rapid than the conventional method of culture isolation and an NT.
Conjunctivitis caused by adenovirus (Ad) is a frequently seen ocular infection. Ad has six subgenera (A to F) and 49 serotypes based on DNA homology and biological and biochemical properties (14) . It has been confirmed by a 14-year national surveillance program monitoring epidemic conjunctivitis that adenoviral conjunctivitis, which includes epidemic keratoconjunctivitis, pharyngoconjunctival fever, and nonspecific follicular conjunctivitis, is caused predominantly by serotypes 3, 4, 8, 11, 19 , and 37 in Japan (2) (3) (4) . Viral infection is spread in families, schools, and offices. There are no effective antiadenoviral drugs, and so prophylaxis is the most important means for preventing adenoviral conjunctivitis. Therefore, a method of diagnosing adenoviral conjunctivitis rapidly and accurately is needed. Ad is usually identified by culture isolation and a neutralization test (NT). However, in culture isolation, formation of cytopathic effects (CPE) often takes at least 2 weeks, especially when Ad8 is inoculated, and in NT, there is cross-reactivity (especially in subgenus D) and insufficiency of anti-Ad serum. Currently, Adenoclone (Cambridge BioScience, Hopkinton, Mass.), one of the substances used for immunoassays, is being used in clinical laboratories, but it has only 51% of the sensitivity of culture methods for conjunctival scrapings (8) . Hence, a rapid, highly sensitive, and practical method of identifying the agent is desirable.
Recently, a procedure called a PCR, which can amplify a few copies of target DNA sequence within only a few hours, was developed. PCR has been used to detect Ad-specific primers in clinical specimens (stool samples and eye swab samples, etc.) (1, 6, 7, 10) . In addition, restriction fragment length polymorphism (RFLP) analysis is useful in molecular biology for differentiating DNA variations. We established a combination of nested PCR to amplify the conserved region for the hexon for detecting Ad and RFLP analysis with three restriction enzymes, EcoT14I, HaeIII, and HinfI. With this combination, it was possible to detect and type 14 prototypes of Ad, including the six serotypes which are the predominant cause of conjunctivitis. We applied our PCR-RFLP method directly to conjunctival scrapings from patients with symptoms of conjunctivitis and found it to be an accurate and rapid method of diagnosing adenoviral conjunctivitis.
MATERIALS AND METHODS
Study group and specimens. The conjunctival scrapings used in this study were collected from June to October 1994 in hospitals in five cities of Japan (Sapporo, Morioka, Ashigara, Matsuyama, and Kumamoto) from 127 patients whose diagnoses were acute conjunctivitis, epidemic keratoconjunctivitis, pharyngoconjunctival fever, or acute follicular conjunctivitis. The specimens were scraped from the lower palpebral conjunctiva with two cotton swabs and collected in two kinds of transport medium (4.5 ml), one for PCR (10 mM Tris [pH 8.0], 1 mM EDTA) and another for cell culture isolation (0.5% bovine serum albumin, 2.5% bouillon, 0.01% gentamycin).
Ad1 to -8, -11, and -19 were obtained from the National Institute of Health (Tokyo, Japan). Ad14, -37, -40, and -41 were obtained from the American Type Culture Collection (Rockville, Md.). Ad1 to -8, -11, -14, and -19 were grown on a monolayer culture of HEp-2 cells in Eagle's minimum essential medium (MEM) (Nissui, Tokyo, Japan) supplemented with 2% fetal calf serum (CSL Limited, Parkville, Australia) and antibiotics. Ad37 was inoculated onto a monolayer culture of HEL cells, and Ad40 and -41 were inoculated onto a monolayer culture of 293 cells. Both of these cell types were in MEM supplemented with 2% fetal calf serum and antibiotics. (13), and -41 (12) . The pair of primers for the first PCR (AdTU7 and AdTU4Ј) was used to amplify a 1,004-bp product corresponding to bp 20,734 to 21,737, and the pair of primers for the second PCR (AdnU-SЈ and AdnU-A) was used to amplify a 956-bp product corresponding to bp 20,743 to 21,698 of the sequenced Ad2 genome (5) ( Table 1) .
(ii) PCR. The primers used for one-step amplification were AdTU7 and AdTU4Ј, and those used for two-step amplification were AdnU-SЈ and AdnU-A. The first PCR amplification was performed with 10-l volumes of prepared conjunctival-scraping suspensions, undiluted or diluted 100-fold in sterilized water. PCR amplifications were conducted in 50-l volumes containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 200 M each deoxynucleoside triphosphate (i.e., dATP, dGTP, dCTP, and dTTP), 0.5 M each primer needed for the specific reaction, and 1 U of thermostable Taq DNA polymerase (Roche Diagnostic Systems, Branchburg, N.J.). PCR was carried out in a Cetus 9600 thermal cycler (Perkin-Elmer Cetus, Emeryville, Calif.) by using a cycle of denaturation at 94ЊC for 1 min, annealing at 50ЊC for 1 min, and primer extension at 72ЊC for 2 min, for 36 cycles. After the last cycle, samples were extended at 72ЊC for 7 min.
As a positive control in all experiments, 1 pg of Ad5 DNA was used per reaction mixture. PCR mixtures with DNA of scrapings from unaffected eyes were used as negative controls.
The nested-PCR amplification was performed with 10 l of one-step-PCRamplified suspensions, undiluted or diluted 100-fold in sterilized water. This PCR amplification was conducted by using the same protocol as used for the first reaction.
After the nested-PCR amplification, 5 l of the reaction mixture was subjected to electrophoresis on a 3% agarose gel containing 0.5 g of ethidium bromide per ml.
Specificity of the nested PCR was evaluated by using nonadenoviral DNA samples from several causative agents of conjunctivitis. Viruses used were herpes simplex virus types 1 and 2 and cytomegalovirus, and bacteria used were Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, a Neisseria sp., Haemophilus influenzae, Pseudomonas aeruginosa, Mycobacterium tuberculosis, a Corynebacterium sp., Escherichia coli, Proteus mirabilis, Klebsiella pneumoniae, Chlamydia trachomatis, and Candida albicans.
To establish the sensitivity of the nested PCR, further amplifications of known amounts of Ad3, -4, -8, -11, -19, and -37 DNAs were performed. After phenolchloroform extraction and ethanol precipitation, the DNA suspensions were diluted in 11 steps to obtain a theoretical range of virus particles from 10 10 to 1 per reaction mixture; 0.384 fg of Ad DNA corresponds to a single copy of linear double-stranded DNA of about 35,000 bp. After the PCR amplification, 5 l of the reaction mixture was subjected to electrophoresis on a 3% agarose gel containing 0.5 g of ethidium bromide per ml.
(iii) Culture isolation. Ad cultures were performed at the Mitsubishi Kagaku Bio-Clinical Laboratories, Inc. (Tokyo, Japan), by using HEp-2 cells, HEL cells, and HeLa cells in tissue culture or microtiter plates. Of the 127 specimens, samples 1 through 90 were inoculated onto HEp-2 cells and HEL cells and samples 91 through 127 were inoculated onto HEp-2 cells, HEL cells, and HeLa cells. Cell cultures that did not show CPE but were PCR positive were passaged 6 times, and those that were both CPE and PCR negative were passaged 2 times. The CPE-negative samples were classified as cell culture negative. Infected cells were identified by the immunofluorescent-antibody technique with Ad monoclonal antibody (Chemicon International, Inc., Temecula, Calif.).
Ad typing. (i) PCR-RFLP analysis. All positive PCR samples were digested by a combination of three restriction endonucleases, EcoT14I, HaeIII, and HinfI and electrophoresed on a 3% agarose gel containing 0.5 g of ethidium bromide per ml, after which the DNA restriction fragments were analyzed.
(ii) NT. Cell cultures showing CPE were typed by using antiadenoviral serum at the Mitsubishi Kagaku Bio-Clinical Laboratories, Inc. The cross-reaction between Ad19 and Ad37 was checked by using antiadenoviral sera against both.
RESULTS
Specificities of the primers. The first set of PCR primers (AdTU7 and AdTU4Ј) amplified 1,004-bp products and the set of nested-PCR primers (AdnU-SЈ and AdnU-A) amplified 956-bp products from DNA samples of all 14 prototypes, including the six serotypes (Ad3, -4, -8, -11, -19, and -37) that predominantly cause conjunctivitis (Fig. 1) . To check the specificity of the PCR assay, we tested nonadenoviral DNA samples (see Materials and Methods) with these two sets of primers. No amplified products were obtained from the nonadenoviral DNA samples (data not shown).
Sensitivity of the primers. After the first amplification it was possible to detect 10 6 virus particles, and after two-step amplification the sensitivity was increased to 10 3 particles (data not shown).
Ad detection. A total of 69 samples (54.3%) were found to be positive for Ad by nested PCR, and 61 of 127 (48.0%) were positive by cell culture isolation. Compared with culture isolation, the PCR method had a sensitivity of 100% (61 of 61). It took about 3 days to detect Ad by the PCR method and an average of 23.4 days to detect Ad by cell culture isolation.
Ad typing. (i) PCR-RFLP analysis for Ad prototypes.
When 956-bp amplified products of the 14 prototypes were tested by our PCR-RFLP method, there were 7, 12 and 6 digestion patterns for EcoT14I, HaeIII, and HinfI, respectively, and the 14 prototypes were completely differentiated by the combination of digestion patterns of these three endonucleases (Fig. 2) .
(ii) PCR-RFLP analysis for clinical specimens. PCR-RFLP analysis was performed for 69 samples (54.3%) that were PCR positive, and they were identified as Ad37 
DISCUSSION
We have established a new method to sensitively, accurately, and rapidly detect and identify human Ad from conjunctival scrapings by PCR-RFLP analysis. This method could completely differentiate 14 prototypes of Ad. The reliability of the new method was evaluated by using clinical specimens. In comparison with culture isolation, the PCR method had a sensitivity of 100% (61 of 61), showing that the method is highly accurate and sensitive. We also performed RFLP with PCR-positive clinical specimens, and the results were completely identical to those obtained by the NT following cell culture isolation.
To check the reaction of our PCR method with other microorganisms, we tested the nonadenoviral DNA samples listed in Materials and Methods and normal conjunctival tissue. The lack of amplified products demonstrated the high level of specificity of our primer sets.
The minimum limit of detection of our nested-PCR assay was 10 3 copies of viral DNA (data not shown). Since it is unknown how many copies of adenoviral DNA are necessary to cause conjunctivitis, further research is desirable. However, the minimum limit of detection of 10 3 copies was sufficient because the PCR assay was more sensitive than culture isolation. The designation of primers for PCR in this study was based on comparison of the hexon gene sequences derived from Ad2, -5 (5), -40 (13), and -41 (12). Allard et al. (1) and Kinchington et al. (7) amplified 308-and 306-bp sequences of Ad DNA, respectively, which are partially located in the basal part of the ␤-barrel-forming P1 domain within the 5Ј region of the hexon (11) . On the other hand, Hierholzer et al. (6) amplified a 161-bp sequence of Ad DNA that is partially located in the P2 domain within the 3Ј region of the hexon (11). Our amplified fragment includes sequences of both domains (11) and is longer than those obtained by the other investigators. The aims of this research were to identify conjunctivitis-causing serotypes among six kinds (Ad3, -4, -8, -11, -19, and -37) and to differentiate Ads by digestion patterns of the long amplified fragment in PCR-RFLP analysis. In addition, Allard et al. (1) and Pring-Åkerblom et al. (10) developed type-specific PCR amplification assays. It is useful to differentiate Ad40 from Ad41, or to differentiate these two enteric Ads from other types of Ad. Since we know six serotypes that cause conjunctivitis, it is difficult to choose specific primers for each serotype. The PCR-RFLP assay that amplifies a long fragment consisting of many restriction endonuclease sites is probably a more useful method for identifying adenoviral conjunctivitis.
It has been reported that the fiber region contains one typespecific determinant, ␥, which reacts with hemagglutination inhibition antibody (9) . The results of PCR analysis with the fiber sequence might be different from ours with the hexon, which is responsible for Ad neutralization (9) , and so further research is needed.
Ad is the most common agent of infectious conjunctivitis in Japan. The standard method for diagnosis of adenoviral conjunctivitis has been generally considered to be a combination of cell culture isolation and an NT. In contrast to the situation with stool, sputum, or urine samples, little proteinaceous materials inhibiting PCR exist in conjunctival-swab samples. Thus, direct PCR-RFLP analysis is probably the best way to diagnose infectious conjunctivitis. The PCR method not only is stable with respect to the biological properties, such as adaptability of cell culture isolation, but also is highly reproducible. Our PCR-RFLP method can accurately detect Ad that was not detected by the conventional method, for example, Ad37 and -8 in this study. Our method also has the advantage of detecting and typing Ad from clinical specimens in a shorter period than that required for cell culture. We intend to apply our PCR-RFLP analysis for Ad surveillance to study the worldwide epidemiology of adenoviral conjunctivitis.
Yamadera et al. (15) reported that 91% of viruses isolated from patients with conjunctivitis in the Ad surveillance study were Ads, whereas the PCR-positive rate for Ads was 54% in this study. Although our rate was lower, the purpose of this study was to evaluate the sensitivity of the PCR-RFLP method for clinical specimens collected from patients with acute follicular conjunctivitis and was not to survey adenoviral epidemiology. The difference was based on the kinds of pathogens and diseases; for example, allergic conjunctivitis was included in our study.
In our report, Ad37 was the predominant type and no Ad19 was found. We used the Ad19 prototype in this PCR-RFLP assay, whereas the results might be more confirmatory with Ad19a, which is a more significant cause of conjunctivitis than the prototype, which is no longer isolated. We will proceed with further research.
In conclusion, our new method of typing human Ad directly from conjunctival scrapings by PCR-RFLP analysis is more 
